Literature DB >> 15213159

Flagella and chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in streptomycin-pretreated mice.

Bärbel Stecher1, Siegfried Hapfelmeier, Catherine Müller, Marcus Kremer, Thomas Stallmach, Wolf-Dietrich Hardt.   

Abstract

Salmonella enterica subspecies 1 serovar Typhimurium is a common cause of gastrointestinal infections. The host's innate immune system and a complex set of Salmonella virulence factors are thought to contribute to enteric disease. The serovar Typhimurium virulence factors have been studied extensively by using tissue culture assays, and bovine infection models have been used to verify the role of these factors in enterocolitis. Streptomycin-pretreated mice provide an alternative animal model to study enteric salmonellosis. In this model, the Salmonella pathogenicity island 1 type III secretion system has a key virulence function. Nothing is known about the role of other virulence factors. We investigated the role of flagella in murine serovar Typhimurium colitis. A nonflagellated serovar Typhimurium mutant (fliGHI) efficiently colonized the intestine but caused little colitis during the early phase of infection (10 and 24 h postinfection). In competition assays with differentially labeled strains, the fliGHI mutant had a reduced capacity to get near the intestinal epithelium, as determined by fluorescence microscopy. A flagellated but nonchemotactic cheY mutant had the same virulence defects as the fliGHI mutant for causing colitis. In competitive infections, both mutants colonized the intestine of streptomycin-pretreated mice by day 1 postinfection but were outcompeted by the wild-type strain by day 3 postinfection. Together, these data demonstrate that flagella are required for efficient colonization and induction of colitis in streptomycin-pretreated mice. This effect is mostly attributable to chemotaxis. Recognition of flagellar subunits (i.e., flagellin) by innate immune receptors (i.e., Toll-like receptor 5) may be less important.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213159      PMCID: PMC427403          DOI: 10.1128/IAI.72.7.4138-4150.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

Review 1.  The role of motility as a virulence factor in bacteria.

Authors:  Christine Josenhans; Sebastian Suerbaum
Journal:  Int J Med Microbiol       Date:  2002-03       Impact factor: 3.473

2.  Green fluorescent protein as a marker for conditional gene expression in bacterial cells.

Authors:  Roy J M Bongaerts; Isabelle Hautefort; Julie M Sidebotham; Jay C D Hinton
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

3.  Lack of flagella disadvantages Salmonella enterica serovar Enteritidis during the early stages of infection in the rat.

Authors:  Jeanette M C Robertson; Norma H McKenzie; Michelle Duncan; Emma Allen-Vercoe; Martin J Woodward; Harry J Flint; George Grant
Journal:  J Med Microbiol       Date:  2003-01       Impact factor: 2.472

4.  Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host.

Authors:  Manja Barthel; Siegfried Hapfelmeier; Leticia Quintanilla-Martínez; Marcus Kremer; Manfred Rohde; Michael Hogardt; Klaus Pfeffer; Holger Rüssmann; Wolf-Dietrich Hardt
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 5.  Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system.

Authors:  Scott R Waterman; David W Holden
Journal:  Cell Microbiol       Date:  2003-08       Impact factor: 3.715

6.  Secreted effector proteins of Salmonella enterica serotype typhimurium elicit host-specific chemokine profiles in animal models of typhoid fever and enterocolitis.

Authors:  Shuping Zhang; L Garry Adams; Jairo Nunes; Sangeeta Khare; Renée M Tsolis; Andreas J Bäumler
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

7.  Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica.

Authors:  Sofia Eriksson; Sacha Lucchini; Arthur Thompson; Mikael Rhen; Jay C D Hinton
Journal:  Mol Microbiol       Date:  2003-01       Impact factor: 3.501

8.  Molecular and phenotypic analysis of the CS54 island of Salmonella enterica serotype typhimurium: identification of intestinal colonization and persistence determinants.

Authors:  Robert A Kingsley; Andrea D Humphries; Eric H Weening; Marcel R De Zoete; Sebastian Winter; Anastasia Papaconstantinopoulou; Gordon Dougan; Andreas J Bäumler
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

9.  Differential accumulation of Salmonella[Cu, Zn] superoxide dismutases SodCI and SodCII in intracellular bacteria: correlation with their relative contribution to pathogenicity.

Authors:  Sergio Uzzau; Lionello Bossi; Nara Figueroa-Bossi
Journal:  Mol Microbiol       Date:  2002-10       Impact factor: 3.501

10.  Salmonella enterica serovar Typhimurium periplasmic superoxide dismutases SodCI and SodCII are required for protection against the phagocyte oxidative burst.

Authors:  Laura M Sly; Donald G Guiney; Neil E Reiner
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more
  157 in total

Review 1.  Taming the elephant: Salmonella biology, pathogenesis, and prevention.

Authors:  Helene L Andrews-Polymenis; Andreas J Bäumler; Beth A McCormick; Ferric C Fang
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

Review 2.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

3.  Diarrhea and colitis in mice require the Salmonella pathogenicity island 2-encoded secretion function but not SifA or Spv effectors.

Authors:  Joshua Fierer; Sharon Okamoto; Ananya Banerjee; Donald G Guiney
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 4.  Effects of flagellin on innate and adaptive immunity.

Authors:  Anna N Honko; Steven B Mizel
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Contribution of flagellin pattern recognition to intestinal inflammation during Salmonella enterica serotype typhimurium infection.

Authors:  Sebastian E Winter; Parameth Thiennimitr; Sean-Paul Nuccio; Takeshi Haneda; Maria G Winter; R Paul Wilson; Joseph M Russell; Thomas Henry; Quynh T Tran; Sara D Lawhon; Gabriel Gomez; Charles L Bevins; Holger Rüssmann; Denise M Monack; L Garry Adams; Andreas J Bäumler
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

6.  A Peptidoglycan Amidase Activator Impacts Salmonella enterica Serovar Typhimurium Gut Infection.

Authors:  Nao Nakamura; Yusuke Hoshino; Takuro Shiga; Takeshi Haneda; Nobuhiko Okada; Tsuyoshi Miki
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

7.  Bacterial colitis increases susceptibility to oral prion disease.

Authors:  Christina J Sigurdson; Mathias Heikenwalder; Giuseppe Manco; Manja Barthel; Petra Schwarz; Bärbel Stecher; Nike J Krautler; Wolf-Dietrich Hardt; Burkhardt Seifert; Andrew J S MacPherson; Irène Corthesy; Adriano Aguzzi
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

8.  Activation of NLRC4 downregulates TLR5-mediated antibody immune responses against flagellin.

Authors:  Wei Li; Jingyi Yang; Ejuan Zhang; Maohua Zhong; Yang Xiao; Jie Yu; Dihan Zhou; Yuan Cao; Yi Yang; Yaoming Li; Huimin Yan
Journal:  Cell Mol Immunol       Date:  2015-04-27       Impact factor: 11.530

9.  Flagellin suppresses epithelial apoptosis and limits disease during enteric infection.

Authors:  Matam Vijay-Kumar; Huixia Wu; Rheinallt Jones; George Grant; Brian Babbin; Timothy P King; Denise Kelly; Andrew T Gewirtz; Andrew S Neish
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

10.  Predataxis behavior in Myxococcus xanthus.

Authors:  James E Berleman; Jodie Scott; Tatiana Chumley; John R Kirby
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.